Alan Martin, MD
Rheumatology · Tulsa, OKNPI 1083677017
Payments from drug & device makers
Across 905 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Genentech, Inc.$4K
- Amgen$3K
- AbbVie$3K
- UCB, Inc.$2K
- GSK$762
- plus $5K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 83 | $4,469 |
| Genentech, Inc. | 4 | $3,762 |
| Amgen(2 entities) | 190 | $3,306 |
| AbbVie | 179 | $2,811 |
| UCB, Inc. | 91 | $1,721 |
| GSK | 46 | $762 |
| Novartis | 51 | $760 |
| Lilly USA, LLC | 41 | $686 |
| Genentech USA, Inc. | 53 | $686 |
| AstraZeneca | 33 | $647 |
| Pfizer | 41 | $568 |
| E.r. Squibb & Sons, L.L.C. | 27 | $409 |
| Aurinia Pharma U.S., Inc. | 20 | $377 |
| Sanofi | 7 | $118 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Sandoz | 5 | $105 |
| Sobi, Inc | 5 | $104 |
| Fresenius Kabi USA, LLC | 5 | $93 |
| Bristol Myers Squibb | 5 | $85 |
| Radius Health, Inc. | 4 | $79 |
| Boehringer Ingelheim | 2 | $30 |
| Antares Pharma, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $23 |
| Mylan Institutional Inc. | 1 | $21 |
| Biocon Biologics Inc | 1 | $20 |
| Abbott | 1 | $16 |
| GE HealthCare | 1 | $15 |
How this compares
$21,951 in reported general payments places this provider in the 75th percentile of 67 rheumatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Tulsa
- Basmah JalilTulsa$5.2M
- James McKayTulsa$945K
- Debbie FoleyTulsa$488K
- William SurbeckTulsa$82K
- Ellen ZanetakisTulsa$80K
- Mary Hinojos MamutTulsa$21K
- Manuel CalvinTulsa$19K
- Michael MalloyTulsa$13K
- Priyatha GarlapatiTulsa$8K
- Lindsay CunninghamTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.